Hologic Announces Financial Results for Fourth Quarter of Fiscal 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Hologic (HOLX) PT Lowered to $48 at Piper Jaffray Following 4Q Release
November 9, 2017 8:19 AM ESTPiper Jaffray lowered its price target on Hologic (NASDAQ: HOLX) to $48.00 (from $51.00) while maintaining a Overweight rating following the company's 4Q earnings report. Hologic reported a 10.5% 4Q17 revenue increase to $802.9M, above $793M consensus. Adjusted EPS of $0.50 beat the Street's $0.49 forecast. Hologic issued 2018 revenue... More
